Understanding Early Antibody Responses to HIV-1
Author Information
Author(s): Mikell Iliyana, Sather D. Noah, Kalams Spyros A., Altfeld Marcus, Alter Galit, Stamatatos Leonidas
Primary Institution: Seattle BioMed, University of Washington, Vanderbilt University, Ragon Institute of Massachusetts General Hospital
Hypothesis
The study aims to determine the timing and characteristics of the earliest cross-neutralizing antibody responses to HIV-1.
Conclusion
Cross-neutralizing antibody responses to HIV-1 typically emerge around 2.5 years after infection, with some cases as early as 1 year.
Supporting Evidence
- Cross-neutralizing antibody responses were detected in 10%-30% of HIV-1 infected individuals.
- Responses typically emerged around 2.5 years post-infection.
- Early responses were linked to specific T cell activation markers.
- Antibodies targeting complex epitopes on the virion-associated envelope spike were crucial for early responses.
Takeaway
When people get HIV, their bodies start making special antibodies to fight it, and this study found that these antibodies usually start showing up about 2.5 years after getting infected.
Methodology
The study analyzed longitudinal plasma samples from HIV-1 infected subjects to assess the timing and characteristics of cross-neutralizing antibody responses.
Potential Biases
Potential biases may arise from the selection of cohorts and the specific characteristics of the subjects studied.
Limitations
The study primarily focused on clade B HIV-1 infections, which may not represent other clades.
Participant Demographics
Participants were HIV-1 infected individuals from the Vanderbilt University and Ragon Institute cohorts, primarily infected with clade B viruses.
Statistical Information
P-Value
0.0026
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website